# Max Healthcare: how the business works

> For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Max Healthcare Institute Limited · NSE: MAXHEALTH · BSE: 543220 · Sector: Healthcare

Updated for Q2 FY27 · checked 12 Nov 2026

This is the plain-text version of https://cityfort.in/stocks/max-healthcare. Source ids in [brackets] refer to the list at the end. Credit: "Cityfort, Max Healthcare: how the business works", with the page URL.

## In short

Patients, insurers and government health schemes pay Max Healthcare for hospital care; drugs and doctors' fees take about ₹42 of every ₹100, and ₹16.9 is left as profit.

- Max Healthcare's press releases headline "network" figures that include partner hospitals owned by societies it does not control. This page uses consolidated figures unless it says network.
- Network operational beds rose from 4,760 to 5,518 in the year to 30 Sep 2026. The company's Aug 2026 presentation plans over 10,000 beds by FY30.

## Key facts

**What does Max Healthcare do?**

Max Healthcare Institute Ltd runs private hospitals in India, mainly in metro cities and especially Delhi NCR. It also runs Max Lab (diagnostic tests) and Max@Home (care at home). Max Healthcare's FY26 consolidated revenue was ₹8,373 crore. [S1, S21, S45]

**How does Max Healthcare make money?**

Max Healthcare charges patients, insurers and government schemes for treatment, surgery, tests and hospital stays. In FY26 Max Healthcare spent about ₹21 of every ₹100 that came in on drugs and consumables and ₹21 on doctors' fees, and kept ₹16.9 as profit. [S1]

**Who pays Max Healthcare?**

In Q2 FY27, self-paying patients and insurers or employers together paid 71.4% of Max Healthcare's network hospital revenue. Government and institutional schemes such as CGHS and ECHS paid 18.4%, and international patients 10.2%. [S21]

**How big is Max Healthcare?**

Max Healthcare's FY26 consolidated revenue was ₹8,373 crore and its profit ₹1,442 crore. On 30 Sep 2026 Max Healthcare's network, including partner hospitals, had 5,518 operational beds and 6,184 beds of capacity. [S1, S21]

**Who owns Max Healthcare?**

On 30 Sep 2026 Max Healthcare's promoter group held 23.71%, almost all through chairman Abhay Soi, with no shares pledged. Foreign investors held 40.52%, Indian institutions 31.00% and other shareholders 4.76%. [S33]

**How did Max Healthcare get listed?**

Max Healthcare did not list through an IPO. NCLT Mumbai sanctioned a merger scheme with Radiant Life Care and Max India on 17 Jan 2020. Max Healthcare's shares then listed on NSE and BSE on 21 Aug 2020. [S5]

**Does Max Healthcare have debt?**

On 31 Mar 2026 Max Healthcare had ₹2,907 crore of borrowings, excluding leases, and ₹701 crore of cash and bank balances. CARE Ratings reaffirmed Max Healthcare's long-term bank facilities at CARE AA+ (Stable) in Oct 2026. [S1, S46]

**What are Max Healthcare's partner hospitals?**

Max Healthcare's partner hospitals are owned by societies, such as Balaji, GM Modi and Devki Devi, that Max Healthcare does not control. Max Healthcare runs them under service agreements, so their revenue is outside its consolidated revenue but inside its network figures. [S21]

**What dividend did Max Healthcare declare for FY26?**

Max Healthcare's board recommended a dividend of ₹2.00 per share for FY26 on 21 May 2026, against ₹1.50 for FY25. That was 13.5% of Max Healthcare's FY26 basic earnings per share of ₹14.83. [S10, S1, S2]

## What does Max Healthcare sell?

Max Healthcare runs large private hospitals that treat serious illness, including surgery, cancer care and transplants. Patients, insurers and schemes pay for each treatment and hospital stay.

- **Hospital treatment:** Inpatient stays and outpatient visits. In Q2 FY27 the network treated 98,464 inpatients and gave about 11.4 lakh outpatient consultations, on 5,518 operational beds. [S21]
- **Transplants:** The company reports about 4,978 liver, 6,329 kidney and 2,348 bone-marrow transplants done to date. [S21]
- **Cancer care:** Oncology was 20.9% of network inpatient gross revenue in Q2 FY27, down from 25.7% a year earlier. [S21]
- **Max Lab:** Diagnostic tests in over 60 cities; it served over 7 lakh patients in Q2 FY27. Revenue was ₹66 crore in Q2 FY27. [S21, S29]
- **Max@Home:** Care services at home, in 15 cities. Revenue was ₹86 crore in Q2 FY27, up 37% on a year earlier. [S21, S29]
- **Running partner hospitals:** Max runs hospitals owned by societies under service agreements and earns fees from them. Their own revenue sits outside consolidated revenue. [S21]

## Who pays Max Healthcare?

- **Self-paying patients and insurers or employers (71.4% of revenue):** Patients who pay themselves, or whose health insurer or employer pays. The company's chart does not let this page split the two, so they are shown together. [S21]
- **Government and institutional schemes (18.4% of revenue):** Schemes such as CGHS (central government staff) and ECHS (ex-servicemen). Their share fell from 21.5% a year earlier, after CGHS and ECHS disempanelled certain hospitals. [S21]
- **International patients (10.2% of revenue):** Patients who travel from other countries for treatment. Their share rose from 9.2% a year earlier. [S21]
- **Customer concentration:** Shares are of Q2 FY27 network hospital revenue (incl. partner hospitals, excluding Max Lab and Max@Home), as the company reports them. The split between self-pay and insurance is not available on this page. [S21]

## Where the money went (FY26)

1. In FY26 Max Healthcare's hospitals and services brought in ₹8,373 crore, plus ₹163 crore of other income.
2. Drugs, consumables and implants took ₹1,790 crore, and doctors' fees ₹1,794 crore.
3. Staff cost ₹1,357 crore, and other running costs ₹1,238 crore, including ₹48 crore of one-off charges.
4. Depreciation of buildings and equipment plus interest took ₹682 crore, and income tax ₹233 crore.
5. What was left was ₹1,442 crore of profit.

Sources: S1, S10.

## Key numbers by year (₹ crore)

Financials: consolidated, ₹ crore. Financial year runs April to March (March year end). — = not shown on the page.

| Year | Revenue | EBITDA | EBITDA margin | Net profit | Net margin | EPS (₹ per share) | Operating cash flow | Capital spending | Free cash flow | Sources |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY22 (restated) | 3,937 | 939 | 23.8% | 605 | 15.4% | 6.25 | 741 | 553 | 187 | S4, S20 |
| FY23 (restated) | 4,563 | 1,241 | 27.2% | 1,104 | 24.2% | 11.38 | 1,284 | 336 | 949 | S3, S19 |
| FY24 (restated) | 5,406 | 1,493 | 27.6% | 1,058 | 19.6% | 10.89 | 1,122 | 786 | 336 | S2, S18 |
| FY25 (restated) | 7,028 | 1,775 | 25.3% | 1,076 | 15.3% | 11.07 | 1,438 | 944 | 493 | S1, S2 |
| FY26 | 8,373 | 2,195 | 26.2% | 1,442 | 17.2% | 14.83 | 1,633 | 1,485 | 149 | S1, S11, S23 |

- EBITDA = profit before interest, tax and wear-and-tear of assets.
- Net profit is the share belonging to the company's owners.

## Balance sheet (as of 31 Mar 2026, ₹ crore)

On 31 Mar 2026 net debt of ₹2,206 crore was about 1.4 times FY26 operating cash flow of ₹1,633 crore (Cityfort calculation from the FY26 annual report). [S1, S7, S21, S23, S31]

| Item | Value |
| --- | --- |
| Total debt | 2,907 |
| Cash and investments | 701 |
| Net debt (debt minus cash) | 2,206 |
| Net worth (shareholders' money) | 10,747 |
| Debt to equity (times) | 0.27 |

- Net debt = borrowings excluding leases (₹2,907 crore) − cash and bank balances (₹701 crore), a Cityfort calculation (S1). Borrowings were ₹565 crore on 31 Mar 2023.
- Lease liabilities (rent owed under leases) were a further ₹572 crore. Including them, the company states debt-to-equity of 0.32.
- The company's own "network net debt", which covers partner hospitals and a put-option liability, was ₹1,908 crore on 31 Mar 2026 and ₹2,369 crore on 30 Sep 2026. Management said on 22 May 2026 that network net debt was "less than 1" times network EBITDA.
- On 30 Sep 2026 borrowings including leases were ₹3,795 crore and cash and bank balances ₹571 crore (half-year statement).
- Goodwill (₹3,488 crore) and other intangible assets (₹2,518 crore) are large. The company says fair-value accounting for the 2020 merger added ₹3,662 crore to the group's assets.

## Who owns Max Healthcare? (shareholding, Q2 FY27)

| Holder | % of shares |
| --- | --- |
| Promoters | 23.71% |
| Promoter shares pledged (% of promoter shares) | 0.0% |
| Foreign institutions (FII) | 40.52% |
| Indian institutions (DII) | 31.0% |
| Public | 4.76% |

Sources: S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44.

## What could go wrong

### Most beds in one region

Hospitals in the Delhi region had 2,676 of 5,518 operational network beds in Q2 FY27. CARE names concentration in metros, especially Delhi NCR, as a weakness. [S21, S45]

What to watch: Beds outside Delhi as Lucknow, Pune, Mohali and Bhubaneswar projects open.

### Government price controls

CARE notes that hospitals are a regulated industry, and that past price caps on stents and knee implants hurt margins. [S45]

What to watch: New price caps on drugs, devices or procedures.

### Payers can drop hospitals from their lists

CGHS and ECHS disempanelled certain Max hospitals, and their share of network hospital revenue fell from 21.5% to 18.4% in a year. In Q2 FY26 cashless service for some standalone health insurers' customers was disrupted, the company says. [S21]

What to watch: The institutional share of hospital revenue (18.4% in Q2 FY27).

### A large building plan

The Aug 2026 presentation estimates ₹6,961 crore of spending on new beds from FY27 to FY30, excluding land. The Gurgaon hospital's first phase has already moved from H1 FY27 to the end of FY27. [S27, S32, S29]

What to watch: Operational beds each quarter against the 601 beds planned for FY27.

### Rising borrowings

Borrowings excluding leases rose from ₹565 crore on 31 Mar 2023 to ₹2,907 crore on 31 Mar 2026. FY26 free cash flow was ₹149 crore. [S3, S1]

What to watch: Borrowings and free cash flow in the FY27 accounts.

### Money tied to hospitals it does not control

Partner hospitals are owned by societies, and their figures in the network numbers are unaudited. The company says it has significant financial exposure to them, and it lent ₹420 crore to other healthcare providers in FY26. [S21, S1]

What to watch: Loans to other healthcare providers in the cash flow statement.

### Tribunal case over Kalinga Hospital

Legal representatives of BRS Capital Two Pte. Limited filed petitions at NCLT Cuttack against Kalinga Hospital, its selling shareholder and Max Healthcare. The matter is listed for 14 Dec 2026. [S50]

What to watch: The company's filings after the 14 Dec 2026 listing.

### Competition from other hospital chains

CARE describes high competition from established brands such as Fortis, Apollo and Medanta. Rivals adding beds in the same cities could slow how fast new Max beds fill. [S45, S21]

What to watch: Network occupancy (77% in Q2 FY27).

## What to watch

Next: Q3 FY27 results, Date not announced yet.

- **Gurgaon Sector-56 hospital:** Management said on 3 Nov 2026 it expects to start phased commissioning of the 500-bed hospital by the end of FY27.
- **Remaining beds at Max Smart and Nanavati:** Management said the balance 205 beds at these two hospitals will open after Diwali puja. Network operational beds were 5,518 on 30 Sep 2026.
- **Kalinga Hospital case:** NCLT Cuttack listed the petitions involving Kalinga Hospital and Max Healthcare for 14 Dec 2026.

## Sources

- S1: Integrated Annual Report FY26. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/annual_reports/AR_29667_MAXHEALTH_2025_2026_A_14660266_08072026194209.pdf (published 8 Jul 2026)
- S2: Annual Report FY25. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/annual_reports/AR_26742_MAXHEALTH_2024_2025_A_04072025211500.pdf (published 4 Jul 2025)
- S3: Annual Report FY24. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/annual_reports/AR_25159_MAXHEALTH_2023_2024_26082024234252.pdf (published 26 Aug 2024)
- S4: Annual Report FY23. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/annual_reports/AR_23467_MAXHEALTH_2022_2023_04092023235420.zip (published 4 Sep 2023)
- S5: Annual Report FY21 (year of the 2020 merger and listing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/annual_reports/AR_19684_MAXHEALTH_2020_2021_07092021233003.zip (published 7 Sep 2021)
- S6: Q2 FY27 results (board outcome, quarter and half-year ended 30 Sep 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_30102026144248_Outcome_BM.pdf (published 30 Oct 2026)
- S7: Q2 FY27 consolidated results, XBRL (integrated filing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750035_30102026051452_WEB.xml (published 30 Oct 2026)
- S8: Q1 FY27 results (board outcome, quarter ended 30 Jun 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_13082026142654_SE_Intimation.pdf (published 13 Aug 2026)
- S9: Q1 FY27 consolidated results, XBRL (integrated filing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1713411_13082026034155_WEB.xml (published 13 Aug 2026)
- S10: Q4 FY26 and FY26 audited results (board outcome 21 May 2026; also dividend, Lucknow capex, registered-office shift). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_21052026162505_SE_Intimation_Board_Meeting_Outcome.pdf (published 21 May 2026)
- S11: Q4 FY26 / FY26 consolidated results, XBRL (integrated filing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1670731_21052026060716_WEB.xml (published 21 May 2026)
- S12: Q3 FY26 results (board outcome, quarter ended 31 Dec 2025). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_05022026133658_SE_Intimation_Board_Meeting_Outcome_sd.pdf (published 5 Feb 2026)
- S13: Q3 FY26 consolidated results, XBRL (integrated filing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1618856_05022026020115_WEB.xml (published 5 Feb 2026)
- S14: Q2 FY26 consolidated results, XBRL (integrated filing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1575998_14112025090755_WEB.xml (published 14 Nov 2025)
- S15: Q1 FY26 consolidated results, XBRL (integrated filing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1510859_13082025010348_WEB.xml (published 13 Aug 2025)
- S16: Q4 FY25 / FY25 consolidated results, XBRL (integrated filing). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1445011_20052025094138_WEB.xml (published 20 May 2025)
- S17: Q3 FY25 consolidated results, XBRL. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_118123_1365717_30012025030002.xml (published 30 Jan 2025)
- S18: Q4 FY24 / FY24 consolidated results, XBRL (cross-check of FY24). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_106721_1134065_22052024055907.xml (published 22 May 2024)
- S19: Q4 FY23 / FY23 consolidated results, XBRL (cross-check of FY23). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_91856_844417_17052023021525.xml (published 17 May 2023)
- S20: Q4 FY22 / FY22 consolidated results, XBRL (FY22 as first reported). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/INDAS_85485_661227_26052022010540_WEB.xml (published 26 May 2022)
- S21: Press release and Earnings Update, Q2 FY27. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_30102026144807_PR_EU_Vf.pdf (published 30 Oct 2026)
- S22: Press release and Earnings Update, Q1 FY27. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_13082026143249_SE_Intimation.pdf (published 13 Aug 2026)
- S23: Press release and Earnings Update, Q4 FY26. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_21052026163050_SE_Intimation_Final.pdf (published 21 May 2026)
- S24: Press release and Earnings Update, Q3 FY26. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_05022026133950_SE_Intimation_Press_Release_and_Earnings_Update_sd.pdf (published 5 Feb 2026)
- S25: Press release and Earnings Update, Q2 FY26. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_14112025204747_SE_Intimation_Press_Release_and_Earnings_Update.pdf (published 14 Nov 2025)
- S26: Press release and Earnings Update, Q4 FY25. Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_20052025144828_SE_Intimation_Press_Release_and_Earnings_Update.pdf (published 20 May 2025)
- S27: Investor presentation, Motilal Oswal Global Investor Conference (Aug 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_17082026221805_SE_Intimation_Investor_Presentation.pdf (published 17 Aug 2026)
- S29: Earnings call transcript, Q2 FY27 (call 3 Nov 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_09112026214212_SE_Intimation_Earnings_Call_Transcript.pdf (published 9 Nov 2026)
- S30: Earnings call transcript, Q1 FY27 (call 14 Aug 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_20082026222821_SE_Intimation_Earnings_Call_Transcript.pdf (published 20 Aug 2026)
- S31: Earnings call transcript, Q4 FY26 (call 22 May 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_29052026175302_SE_Intimation_Earnings_Call_Transcript.pdf (published 29 May 2026)
- S32: Earnings call transcript, Q3 FY26 (call 6 Feb 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_12022026222827_SE_Intimation_Earnings_Call_Transcript.pdf (published 12 Feb 2026)
- S33: Shareholding pattern as of 30 Sep 2026 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1740060_16102026044443_WEB.xml (published 16 Oct 2026)
- S34: Shareholding pattern as of 30 Jun 2026 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1695815_17072026102318_WEB.xml (published 17 Jul 2026)
- S35: Shareholding pattern as of 31 Mar 2026 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1655650_20042026101712_WEB.xml (published 20 Apr 2026)
- S36: Shareholding pattern as of 31 Dec 2025 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1601849_15012026100140_WEB.xml (published 15 Jan 2026)
- S37: Shareholding pattern as of 30 Sep 2025 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1553714_18102025052603_WEB.xml (published 18 Oct 2025)
- S38: Shareholding pattern as of 30 Jun 2025 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_1490061_22072025115443_WEB.xml (published 18 Jul 2025)
- S39: Shareholding pattern as of 31 Mar 2025 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_197316_1415268_15042025081036_WEB.xml (published 15 Apr 2025)
- S40: Shareholding pattern as of 31 Dec 2024 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_195721_1353787_20012025071631_WEB.xml (published 20 Jan 2025)
- S41: Shareholding pattern as of 30 Sep 2024 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_192919_1277989_18102024050228_WEB.xml (published 18 Oct 2024)
- S42: Shareholding pattern as of 30 Jun 2024 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_189697_1188255_16072024082231_WEB.xml (published 16 Jul 2024)
- S43: Shareholding pattern as of 31 Mar 2024 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_187359_1097099_17042024084931_WEB.xml (published 17 Apr 2024)
- S44: Shareholding pattern as of 31 Dec 2023 (XBRL). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/xbrl/SHP_184249_1021777_15012024065843_WEB.xml (published 15 Jan 2024)
- S45: CARE Ratings press release: Max Healthcare Institute Ltd, ratings reaffirmed (10 Oct 2025). CARE Ratings Ltd. https://www.careratings.com/upload/CompanyFiles/PR/202510141054_Max_Healthcare_Institute_Limited.pdf (published 10 Oct 2025)
- S46: Intimation: CARE reaffirms CARE AA+ (Stable) / CARE A1+ (9 Oct 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_09102026115625_SE_Intimation_Credit_Rating.pdf (published 9 Oct 2026)
- S47: Intimation: CARE upgrades Crosslay Remedies Ltd (formerly Jaypee Healthcare) to CARE AA+ (Stable) (9 Oct 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_09102026222417_SE_Intimation.pdf (published 9 Oct 2026)
- S48: Board outcome: agreement to acquire ~58.39% of Kalinga Hospital Ltd, Bhubaneswar (8 Apr 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_08042026122057_SE_Intimation_Board_Meeting_Outcome_VF_.pdf (published 8 Apr 2026)
- S49: Infusion of ~Rs 87.87 crore in Kalinga Hospital Ltd via rights issue (3 Sep 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_03092026152852_SE_Disclosure.pdf (published 3 Sep 2026)
- S50: Reg. 30 update: NCLT Cuttack petitions by BRS Capital Two Pte relating to Kalinga Hospital, next date 14 Dec 2026 (3 Nov 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_03112026221201_SE_Disclosure.pdf (published 3 Nov 2026)
- S51: Reg. 30 update: NCLT Cuttack hearing adjourned (29 Oct 2026). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_29102026212151_SE_Disclosure.pdf (published 29 Oct 2026)
- S52: SPA to acquire 100% of Yerawada Properties Pvt Ltd (Pune hospital project) (18 Dec 2025). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_18122025110646_SE_Intimation_Acquisition_Purchase_of_Land.pdf (published 18 Dec 2025)
- S53: Strategic collaboration with Lakshdeep Group to acquire Jaypee Healthcare Ltd (13 Sep 2024). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_13092024130526_SE_Intimation.pdf (published 13 Sep 2024)
- S54: Board outcome: fund infusion in Jaypee Healthcare, Nirogi trust and Eqova (30 Jan 2025). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_30012025141928_BM_Outcome.pdf (published 30 Jan 2025)
- S55: Board outcome 20 May 2025: S.R. Batliboi & Co. LLP appointed statutory auditors (Deloitte term ends). Max Healthcare Institute Ltd (filed with NSE/BSE). https://nsearchives.nseindia.com/corporate/MAXHEALTH_20052025150641_SE_Inti_Final.pdf (published 20 May 2025)
- S56: NSE capital-market bhavcopy, 11 Nov 2026. NSE (nsearchives.nseindia.com). https://nsearchives.nseindia.com/content/cm/BhavCopy_NSE_CM_0_0_0_20261111_F_0000.csv.zip (published 11 Nov 2026)
